ATE349527T1 - Gruppe a streptokokken-impfstoff - Google Patents

Gruppe a streptokokken-impfstoff

Info

Publication number
ATE349527T1
ATE349527T1 AT98946991T AT98946991T ATE349527T1 AT E349527 T1 ATE349527 T1 AT E349527T1 AT 98946991 T AT98946991 T AT 98946991T AT 98946991 T AT98946991 T AT 98946991T AT E349527 T1 ATE349527 T1 AT E349527T1
Authority
AT
Austria
Prior art keywords
group
immunogenic
streptococci
immune response
peptide
Prior art date
Application number
AT98946991T
Other languages
English (en)
Inventor
James B Dale
Original Assignee
Univ Tennessee Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tennessee Res Foundation filed Critical Univ Tennessee Res Foundation
Application granted granted Critical
Publication of ATE349527T1 publication Critical patent/ATE349527T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT98946991T 1997-09-12 1998-09-14 Gruppe a streptokokken-impfstoff ATE349527T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5863597P 1997-09-12 1997-09-12

Publications (1)

Publication Number Publication Date
ATE349527T1 true ATE349527T1 (de) 2007-01-15

Family

ID=22018009

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98946991T ATE349527T1 (de) 1997-09-12 1998-09-14 Gruppe a streptokokken-impfstoff

Country Status (8)

Country Link
EP (1) EP1003875B1 (de)
JP (1) JP2001515723A (de)
AT (1) ATE349527T1 (de)
AU (1) AU751009B2 (de)
CA (1) CA2303478C (de)
DE (1) DE69836744T2 (de)
ES (1) ES2280101T3 (de)
WO (1) WO1999013084A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03003690A (es) 2000-10-27 2004-05-05 Chiron Spa Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
GB2370770B (en) * 2001-01-03 2005-06-01 Simon Connolly Uses of Streptococcus Vaccines
ATE557041T1 (de) 2001-05-18 2012-05-15 Us Gov Health & Human Serv Peptid-vakzinen gegen streptokokken der gruppe a
AU2011232787B2 (en) * 2001-05-18 2013-05-02 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Peptide vaccines against group A streptococci
AU2008203277B2 (en) * 2001-05-18 2011-07-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention, Technology Transfer Office Peptide vaccines against group A streptococci
WO2003004650A2 (en) 2001-07-06 2003-01-16 Shire Biochem Inc. Group b streptococcus antigens and corresponding dna fragments
MXPA04003852A (es) * 2001-10-26 2005-02-17 Univ Tennessee Res Foundation Composiciones de vacuna estreptococica multivalente, y metodos para sus uso.
US7255867B2 (en) 2002-11-15 2007-08-14 Id Biomedical Corporation Of Quebec Vaccine
PT1648500E (pt) 2003-07-31 2014-10-10 Novartis Vaccines & Diagnostic Composições imunogénicas para estreptococos piogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2006078318A2 (en) 2004-07-29 2006-07-27 Novartis Vaccines And Diagnostics Inc. Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
CA2583803C (en) 2004-10-08 2014-11-25 Giuliano Bensi Immunogenic and therapeutic compositions for streptococcus pyogenes
EP1857640A3 (de) 2006-05-10 2010-05-05 Silicon Fire AG Neuartiger kaskadierter Kraftwerksprozess und Verfahren zum Bereitstellen von reversibel einsetzbaren Wasserstoffträgern in einem solchen Kraftwerksprozess
CA2699513C (en) 2007-09-12 2018-03-13 Novartis Ag Gas57 mutant antigens and gas57 antibodies
PT2235046E (pt) 2007-12-21 2012-10-26 Novartis Ag Formas mutantes de estreptolisina o
CL2013002782A1 (es) * 2013-09-27 2014-04-25 Univ Pontificia Catolica Chile Formulación inmunogénica para inducir la respuesta inmune en un sujeto que comprende una mezcla de bacterias no patógenas que expresan cada una un segmento hipervariable de la proteína m de diferentes streptococcus pyogenes; uso de la formulación para producir una vacuna; método para producir vacuna

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123579C (en) * 1992-09-16 2005-05-10 James B. Dale Recombinant multivalent m protein vaccine

Also Published As

Publication number Publication date
DE69836744D1 (de) 2007-02-08
CA2303478A1 (en) 1999-03-18
AU9388498A (en) 1999-03-29
EP1003875A1 (de) 2000-05-31
ES2280101T3 (es) 2007-09-01
DE69836744T2 (de) 2007-10-04
AU751009B2 (en) 2002-08-08
WO1999013084A1 (en) 1999-03-18
CA2303478C (en) 2008-09-02
JP2001515723A (ja) 2001-09-25
WO1999013084A9 (en) 1999-05-27
EP1003875B1 (de) 2006-12-27

Similar Documents

Publication Publication Date Title
ATE349527T1 (de) Gruppe a streptokokken-impfstoff
ATE204300T1 (de) Zielzellen-bindende chimäre peptide
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
EP1619202A3 (de) Immunotherapeutische Methoden mit Verwendung von WT-1 and GATA-1 Epitopen
ATE366313T1 (de) Antigene peptide aus neisseria
DK0477231T3 (da) Immunoaktive peptider og antistoffer, og deres anvendelse til anti-allergibehandling
CY1107706T1 (el) Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea)
EP2011510A3 (de) Pharmazeutische Zusammensetzungen, die immunologisch aktive Herpes simplex Virus Proteinfragmente enthalten
EP1420821B8 (de) Immunologisch bedeutende herpes-simplex-virus-antigene und verfahren für ihre verwendung
HUT68554A (en) Immunogenic carrier system eliciting an immuneresponse against gnrh, recombinant dna sequence coding for it and its use
BR9710975A (pt) Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
MX9703676A (es) Inmunogenos para estimular la inmunidad de las mucosas.
DE60234475D1 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
AU6961601A (en) Transport peptides among which c-terminal E<sup>rns</sup> peptide and analogues thereof
WO2000029434A3 (en) PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF
NO20005081D0 (no) Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav
CA2128407A1 (en) Synthetic peptides for a rubella vaccine
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
WO2002044202A3 (fr) Peptides immunogeniques mutes derives de r9m, polynucleotides les codant et leurs usages therapeutiques
PE20010316A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS, PEPTIDOS Y PROTEINAS FlgE RELACIONADOS Y SUS USOS
PE20010239A1 (es) Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos
DE69928947D1 (de) Moraxella catarrhalis basb034 polypeptide und verwendungen davon
NZ219192A (en) Peptides related to p97 melanoma-associated peptide, recombinant virus and vaccines
GB9910375D0 (en) Vaccine composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties